IL6 and myeloid sarcoma: We can refer only to previous reports, which showed that IL-17 (20 ng/ml) increases the secretion of IL-6 and IL-8, inducing rheumatoid arthritis (RA) [44], and has immunomodulatory effects on multiple sclerosis (MS) [45].